Aikawa Yoshiyuki 4

What Happened

• Aikawa Yoshiyuki, reported as a 10% owner of SBC Medical Group Holdings Inc (SBC), sold 3,100,000 SBC shares on April 21, 2026. The reported transaction price was $3.02 per share (net price received noted as $3.0225 per share), for total proceeds of approximately $9,369,750. The sale was effected pursuant to an underwritten public offering that closed on April 21, 2026.

Key Details

• Transaction date: 2026-04-21 (Sale)
• Reported price: $3.02 per share; footnote reports net price received $3.0225 per share
• Shares sold: 3,100,000; Approx. proceeds: $9,369,750
• Shares owned after transaction: not specified in the provided excerpt; filing notes indirect beneficial ownership of 861,600 SBC shares through Aikawa Equity Management Co., Ltd. (AEM) and additional holdings held by Aikawa Investment Co., Ltd.
• Notable footnotes:
  • F1: Sale proceeds reflect an underwritten public offering that closed Apr 21, 2026.
  • F2: 861,600 shares reported as indirectly owned via AEM (Aikawa owns 8,616 AEM shares; each AEM share = 100 SBC shares); he disclaims control of AEM.
  • F3: References shares held by Aikawa Investment Co., Ltd. after a corporate name/form change.
• Filing date: 2026-04-23 — filed two days after the transaction, which appears timely under Section 16 reporting rules.

Context

• This was a sale by a 10% owner in connection with an underwritten offering, not an open-market purchase or option exercise. Sales by large holders can be for many reasons (liquidity, offering mechanics, diversification); the filing itself does not state motivation. For retail investors, purchases tend to be more informative about insider conviction; this filing documents a material disposal tied to an offering.